![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Therapies And Lifestyle Changes:](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Therapies And Lifestyle Changes:
Description
Alongside this reason, his doctor also recommended it
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Therapies And Lifestyle Changes:](https://images.healthandme.com/thumb/msid-154428820,thumbsize-570628,width-390,height-220,resizemode-3/154428820.jpg)
Reassess at intervals If you are feeling no effect even after several weeks, reconsider whether to continue the medication
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Therapies And Lifestyle Changes:](https://verityhealthpnw.com/wp-content/uploads/2025/08/GLP-1-benefits-article-featured-image.png)
Important observations All five clinical trials that were included in the analysis reported GLP-1 receptor agonist-mediated reduction in substance use disorder, with two trials respectively reporting a significant therapeutic impact of GLP-1 receptor agonist in reducing alcohol use disorder and nicotine use disorder
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Therapies And Lifestyle Changes:](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41569-023-00849-3/MediaObjects/41569_2023_849_Fig5_HTML.png)
Three-year efficacy and safety of exenatide once weekly: a pooled analysis of three trials
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Therapies And Lifestyle Changes:](https://dm5migu4zj3pb.cloudfront.net/manuscripts/99000/99934/medium/JCI99934.ga.jpg)
